Echocardiographic effects of sodium-glucose cotransporter 2 inhibitors in single ventricle circulatory failure
Echocardiographic signals of improved ventricular function were observed in the first year of SGLT2i therapy in patients with SVF.
Authors
- J. Wouter Jukema (ORCID: https://orcid.org/0000-0002-3246-8359)
- Niki L. Walker (ORCID: https://orcid.org/0000-0001-6676-1097)
- Monique R.M. Jongbloed
- Amanda Hunter (ORCID: https://orcid.org/0000-0002-7089-1190)
- Philippine Kiès (ORCID: https://orcid.org/0000-0002-1283-1122)
- Gruschen Veldtman (ORCID: https://orcid.org/0000-0002-9336-2662)
- Madelien V. Regeer (ORCID: https://orcid.org/0000-0002-1562-8365)
- Anastasia D. Egorova (ORCID: https://orcid.org/0000-0001-9312-2338)
- Ralph M.L. Neijenhuis
- Eduard R. Holman (ORCID: https://orcid.org/0000-0001-9705-9962)
Institutions
- Leiden University Medical Center (NL)
- Golden Jubilee National Hospital (GB)
- Netherlands Heart Institute (NL)
- Helen DeVos Children's Hospital (US)
Publication Details
- Journal
- International Journal of Cardiology Congenital Heart Disease
- Published
- 2025-06-21
- DOI
- https://doi.org/10.1016/j.ijcchd.2025.100603
- Citations
- 1
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- AstraZeneca
- Stichting de Drie Lichten
- Koninklijke Nederlandse Akademie van Wetenschappen